Logo image of PMAX

POWELL MAX LTD-CL A (PMAX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PMAX - VGG7200G1182 - Common Stock

1.65 USD
+0.06 (+3.77%)
Last: 11/26/2025, 8:00:00 PM
1.65 USD
0 (0%)
After Hours: 11/26/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PMAX. PMAX was compared to 237 industry peers in the Capital Markets industry. PMAX may be in some trouble as it scores bad on both profitability and health. PMAX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PMAX had negative earnings in the past year.
PMAX Yearly Net Income VS EBIT VS OCF VS FCFPMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

PMAX's Return On Assets of -64.18% is on the low side compared to the rest of the industry. PMAX is outperformed by 95.78% of its industry peers.
With a Return On Equity value of -102.36%, PMAX is not doing good in the industry: 87.34% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -64.18%
ROE -102.36%
ROIC N/A
ROA(3y)0.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMAX Yearly ROA, ROE, ROICPMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 42.02%, PMAX is in line with its industry, outperforming 47.26% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for PMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMAX Yearly Profit, Operating, Gross MarginsPMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PMAX has less shares outstanding
Compared to 1 year ago, PMAX has an improved debt to assets ratio.
PMAX Yearly Shares OutstandingPMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 1M 2M 3M
PMAX Yearly Total Debt VS Total AssetsPMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that PMAX is in the distress zone and has some risk of bankruptcy.
PMAX's Altman-Z score of 0.97 is in line compared to the rest of the industry. PMAX outperforms 53.59% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that PMAX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, PMAX is in the better half of the industry, outperforming 74.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACCN/A
PMAX Yearly LT Debt VS Equity VS FCFPMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

PMAX has a Current Ratio of 1.27. This is a normal value and indicates that PMAX is financially healthy and should not expect problems in meeting its short term obligations.
PMAX has a Current ratio (1.27) which is comparable to the rest of the industry.
A Quick Ratio of 1.27 indicates that PMAX should not have too much problems paying its short term obligations.
PMAX has a Quick ratio of 1.27. This is comparable to the rest of the industry: PMAX outperforms 59.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
PMAX Yearly Current Assets VS Current LiabilitesPMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

PMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -342.17%.
The Revenue for PMAX has decreased by -25.77% in the past year. This is quite bad
EPS 1Y (TTM)-342.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1808.86%
Revenue 1Y (TTM)-25.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMAX Yearly Revenue VS EstimatesPMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PMAX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMAX Price Earnings VS Forward Price EarningsPMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMAX Per share dataPMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PMAX!.
Industry RankSector Rank
Dividend Yield N/A

POWELL MAX LTD-CL A

NASDAQ:PMAX (11/26/2025, 8:00:00 PM)

After market: 1.65 0 (0%)

1.65

+0.06 (+3.77%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.77M
Revenue(TTM)60.41M
Net Income(TTM)-38.44M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 3.93
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.69
BVpS1.67
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.18%
ROE -102.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.02%
FCFM N/A
ROA(3y)0.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 0.97
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)16.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-342.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1808.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-336.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-289.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-260.44%
OCF growth 3YN/A
OCF growth 5YN/A

POWELL MAX LTD-CL A / PMAX FAQ

What is the fundamental rating for PMAX stock?

ChartMill assigns a fundamental rating of 1 / 10 to PMAX.


What is the valuation status for PMAX stock?

ChartMill assigns a valuation rating of 0 / 10 to POWELL MAX LTD-CL A (PMAX). This can be considered as Overvalued.


What is the profitability of PMAX stock?

POWELL MAX LTD-CL A (PMAX) has a profitability rating of 0 / 10.


How financially healthy is POWELL MAX LTD-CL A?

The financial health rating of POWELL MAX LTD-CL A (PMAX) is 3 / 10.